Bath & Body Works Q2 profit beats on online shopping; lifts EPS guidance
BBWI•Q2 results beat expectations
Bath & Body Works said second-quarter net sales fell 2.3% but met analyst expectations, while adjusted earnings per share beat Wall Street estimates.
The U.S. personal care retailer reported Q2 sales of $1.50 billion, in line with the consensus estimate, and adjusted EPS of $0.31 versus the $0.24 expected by analysts.
Analyst coverage and valuation
The current average analyst rating on the shares is hold, with 4 strong buy or buy ratings, 13 hold ratings and 1 sell or strong sell rating.
The average consensus recommendation for the miscellaneous specialty retailers peer group is buy.
Wall Street's median 12-month price target for Bath & Body Works, Inc. is $23.00, about 30.8% above its Aug. 25 closing price of $17.58.
The stock recently traded at 6 times next-12-month earnings, versus a P/E of 7 three months ago.
